EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Artificial intelligence framework for lung cancer nodule segmentation and classification using convolutional neural network—from imaging to diagnosis

Ashwin Kumar Azhagarasan, Prashanthi Bhaskaran, Arunkumar Ramachandran, Kalpana Sivalingam

Exploration of Medicine · 01.07.2025 · 6

DOI: 10.37349/emed.2025.1001341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration of Medicine, online erschienen am 01.07.2025. Verfasst von Ashwin Kumar Azhagarasan und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Lung cancer is a leading cause of cancer-related deaths globally, where early and accurate diagnosis significantly improves survival rates. This study proposes an AI-based diagnostic framework integrating U-Net for lung nodule segmentation and a custom convolutional neural network (CNN) for binary classification of nodules as benign or malignant.

Methods

The model was developed using the Barnard Institute of Radiology (BIR) Lung CT dataset. U-Net was used for segmentation, and a custom CNN, compared with EfficientNet B0, VGG-16, and Inception v3, was implemented for classification. Due to limited subtype labels and diagnostically ambiguous “suspicious” cases, classification was restricted to a binary task. These uncertain cases were reserved for validation. Overfitting was addressed through stratified 5-fold cross-validation, dropout, early stopping, L2 regularization, and data augmentation.

Results

EfficientNet B0 achieved ~99.3% training and ~97% validation accuracy. Cross-validation yielded consistent metrics (accuracy: 0.983 ± 0.014; F1-score: 0.983 ± 0.006; AUC = 0.990), confirming robustness. External validation on the LIDC-IDRI dataset demonstrated generalizability across diverse populations.

Conclusions

The proposed AI model shows strong potential for clinical deployment in lung cancer diagnosis. Future work will address demographic bias, expand multi-center data inclusion, and explore regulatory pathways for real-world integration.

Zitieren

APA

Azhagarasan, A. K., Bhaskaran, P., Ramachandran, A., & Sivalingam, K. (2025). Artificial intelligence framework for lung cancer nodule segmentation and classification using convolutional neural network—from imaging to diagnosis. Exploration of Medicine, 6. https://doi.org/10.37349/emed.2025.1001341

Vancouver

Azhagarasan AK, Bhaskaran P, Ramachandran A, Sivalingam K. Artificial intelligence framework for lung cancer nodule segmentation and classification using convolutional neural network—from imaging to diagnosis. Exploration of Medicine. 2025;6. doi:10.37349/emed.2025.1001341

BibTeX
@article{Azhagarasan2025,
  author = {Azhagarasan, Ashwin Kumar and Bhaskaran, Prashanthi and Ramachandran, Arunkumar and Sivalingam, Kalpana},
  title = {Artificial intelligence framework for lung cancer nodule segmentation and classification using convolutional neural network—from imaging to diagnosis},
  journal = {Exploration of Medicine},
  year = {2025},
  volume = {6},
  doi = {10.37349/emed.2025.1001341}
}
Kostenlos starten →